Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Post by MarketMoneyon Dec 21, 2020 7:05pm
430 Views
Post# 32158094

I don’t think the market is waiting for Aristotle...

I don’t think the market is waiting for Aristotle...

It's just waiting until a capitulation is done or enough shares are pilling up on the ask from discourage investors and grab as many they can in a massive purchase order. It only takes a major player to do the first move and everyones elses will follow. 

Not many sellers are willing to sell, that's why shorter are almost gone of the game now. It like a  being in a western movie where everyone is waiting for the first one to shoot.

Company is making money and has positive cashflow to sustain bussiness by itself without any further financing. The shareprice moves because of demand (bid) and supply (Ask) and not because of what we think is good or bad, right now supply is greater as demand is shy.....but not shy for long, patience is a virtue.



 


 

<< Previous
Bullboard Posts
Next >>